Skip to main content
رجوع
Watch Compare

MARIMED INC.

جودة البيانات: 100%
MRMD
OTC Manufacturing Chemicals
KWD 0.07
▲ KWD 0.00 (1.31%)
6 months return
—
Momentum
Neutral
5Y revenue growth
7.10%

النمو

Revenue Growth (5Y)
7.10%
أعلى من متوسط القطاع (1.72%)
Revenue (1Y)1.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-25.69%
أعلى من متوسط القطاع (-54.68%)
ROIC-1.47%
Net Margin-9.06%
Op. Margin-1.76%

الأمان

Debt / Equity
1.40
أعلى من متوسط القطاع (0.30)
Current Ratio1.06
Interest Coverage-0.38

التقييم

PE (TTM)
-1.81
أقل من متوسط القطاع (-1.50)
P/B Ratio0.48
EV/EBITDA18.13
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 7.10% annually over 5 years — modest growth
Generating 6.53 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.92%
Capital efficient — spends only 0.73% of revenue on capex

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

محلل 1
Buy
+258.2%
upside to target
الحالي
KWD 0.07
Consensus Target
KWD 0.25
KWD 0.25
أدنى
KWD 0.25
أعلى
التوقعات
ربحية السهم المستقبلية
-KWD 0.03
الإيرادات المقدّرة
171.70 M

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.01 · Rev Est: 38.73 M
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 0.01 KWD 0.00 KWD 0.00 KWD 0.01 — —
Estimate -KWD 0.01 -KWD 0.01 -KWD 0.01 -KWD 0.01 -KWD 0.01 -KWD 0.01
المفاجأة -0.50% +109.90% +20.00% +157.00% — —

Growth

Rev 5Y: 7.10% · Earnings 1Y: N/A
Revenue Growth (1Y) 1.18% Revenue Growth (3Y) 3.71%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 7.10% Earnings Growth (5Y) N/A

Profitability

ROE: -25.69% · Net Margin: -9.06%
Revenue (TTM) 159.83 M Net Income (TTM) -14.48 M
ROE -25.69% ROA -7.07%
Gross Margin 36.22% Operating Margin -1.76%
Net Margin -9.06% Free Cash Flow (TTM) 6.53 M
ROIC -1.47% FCF Growth (3Y) N/A

Safety

D/E: 1.40 · Current: 1.06
Debt / Equity 1.40 Current Ratio 1.06
Interest Coverage -0.38 Asset Turnover 0.78
Working Capital 3.51 M Tangible Book Value 13.65 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -1.81 · EV/EBITDA: 18.13
P/E Ratio -1.81 Forward P/E N/A
P/B Ratio 0.48 P/S Ratio 0.16
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 18.13 Fwd EV/EBITDA N/A
Forward P/S 0.15 Fwd Earnings Yield N/A
FCF Yield 24.86%
Market Cap 26.26 M Enterprise Value 95.90 M

Per Share

EPS: -0.04 · FCF/Share: 0.02
EPS (Diluted TTM) -0.04 Revenue / Share 0.40
FCF / Share 0.02 OCF / Share 0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: -45.07% · CapEx/Rev: 0.73%
CapEx / Revenue 0.73% FCF Conversion -45.07%
SBC-Adj. FCF 4.77 M Growth Momentum -5.92

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 159.83 M 157.96 M 148.60 M 134.01 M 121.46 M
Net Income -14.48 M -12.16 M -16.03 M 13.47 M 7.22 M
EPS (Diluted) -0.04 -0.03 -0.04 0.04 0.02
Gross Profit 57.88 M 62.87 M 65.92 M 63.96 M 66.26 M
Operating Income -2.82 M 2.91 M 14.39 M 20.37 M 26.86 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 8.11 M 7.91 M 5.55 M — —
Interest Expense 7.50 M 6.94 M 9.19 M 1.69 M 2.36 M
Income Tax 3.59 M 8.16 M 9.41 M 5.89 M 16.19 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 202.57 M 206.99 M 196.12 M 152.20 M 123.20 M
Total Liabilities 137.83 M 128.11 M 107.21 M 57.17 M 49.18 M
Shareholders' Equity 50.01 M 59.88 M 69.91 M 57.31 M 36.30 M
Total Debt 76.04 M 78.19 M — — —
Cash & Equivalents — 7.28 M 14.65 M 9.74 M 29.68 M
Current Assets 59.29 M 53.51 M 51.43 M 44.15 M 44.61 M
Current Liabilities 59.07 M 48.68 M 30.86 M 26.49 M 27.22 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -1.8 -1.5
P/B 0.5 1.6
ROE % -25.7 -54.7
Net Margin % -9.1 -41.5
Rev Growth 5Y % 7.1 1.7
D/E 1.4 0.3